Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Stromal Sarcoma”

378 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 378 results

Not applicableStudy completedNCT06856590
What this trial is testing

ZINCLO-HAND: Zinc and Clobetasol for the Prevention of Regorafenib-Induced Hand-Foot Skin Reaction

Who this might be right for
Hand-Foot Skin Reaction (HFSR)
Gazi University 150
Not applicableUnknownNCT04927260
What this trial is testing

French Long Term Registry With Longitudinal Follow up of PDGFRA D842V-GIST Patients

Who this might be right for
GISTGIST, MalignantPDGFR-Alpha D842V
Centre Leon Berard 25
Testing effectiveness (Phase 2)Study completedNCT00237185
What this trial is testing

The Efficacy and Safety of Imatinib Mesylate in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing C-kit Gene

Who this might be right for
Unresectable or Metastatic Malignant Gastrointestinal Stromal Tumor (GIST)
Novartis Pharmaceuticals 148
Early research (Phase 1)Temporarily pausedNCT04714983
What this trial is testing

DNX-2440 for Resectable Colorectal Liver Metastasis

Who this might be right for
Liver MetastasesLiver Metastasis Colon CancerColorectal Cancer+8 more
DNAtrix, Inc. 30
Not applicableStudy completedNCT00580281
What this trial is testing

Effect of Imatinib on Bone Metabolism in Patients With Chronic Myelogenous Leukemia or Gastrointestinal Stromal Tumors

Who this might be right for
Gastric CancerLeukemiaChronic Myelogenous Leukemia
Memorial Sloan Kettering Cancer Center 33
Testing effectiveness (Phase 2)Study completedNCT00385203
What this trial is testing

The Biological Activity of Cediranib (AZD2171) in Gastro-Intestinal Stromal Tumours(GIST).

Who this might be right for
Gastrointestinal Stromal TumorsSoft Tissue Sarcomas
AstraZeneca 35
Testing effectiveness (Phase 2)Study completedNCT01874665
What this trial is testing

Trial of Ponatinib in Participants With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor

Who this might be right for
GIST
Ariad Pharmaceuticals 45
Testing effectiveness (Phase 2)UnknownNCT01541709
What this trial is testing

Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation: KENEDI

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 23
Early research (Phase 1)Study completedNCT02574663
What this trial is testing

TGR-1202 Alone and in Combination With Either Nab-paclitaxel + Gemcitabine or With FOLFOX in Patients With Select Relapsed or Refractory Solid Tumors

Who this might be right for
Pancreatic CancerColorectal CancerRectal Cancer+3 more
TG Therapeutics, Inc. 66
Not applicableLooking for participantsNCT03602092
What this trial is testing

Observational Registry Data on GIST Patients

Who this might be right for
Gastrointestinal Stromal Tumors
National Health Research Institutes, Taiwan 3,000
Large-scale testing (Phase 3)Ended earlyNCT00751036
What this trial is testing

Nilotinib 800 Mg And Imatinib 800 Mg For The Treatment Of Patients With Gastrointestinal Stromal Tumors (Gist) Refractory To Imatinib 400 Mg

Who this might be right for
Gastrointestinal Stromal Tumors
Novartis Pharmaceuticals 94
Testing effectiveness (Phase 2)Study completedNCT01294202
What this trial is testing

Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Astex Pharmaceuticals, Inc. 26
Testing effectiveness (Phase 2)Looking for participantsNCT04933669
What this trial is testing

Prospective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors

Who this might be right for
Progression-free SurvivalGastrointestinal Stromal TumorNeoadjuvant
First Affiliated Hospital of Zhejiang University 122
Testing effectiveness (Phase 2)Active Not RecruitingNCT01991379
What this trial is testing

MEK162 in Combination With Imatinib Mesylate in Patients With Untreated Advanced Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Gastrointestinal Stromal Tumor (GIST)
Memorial Sloan Kettering Cancer Center 75
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Not applicableEnded earlyNCT00087191
What this trial is testing

EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer

Who this might be right for
Advanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)Study completedNCT04282980
What this trial is testing

DCC-2618 (Ripretinib) In Patients With With Advanced Gastrointestinal Stromal Tumors (GIST)

Who this might be right for
Gastrointestinal Stromal Tumors
Zai Lab (Shanghai) Co., Ltd. 39
Not applicableLooking for participantsNCT07522762
What this trial is testing

Long-term Survivorship Challenges of Advanced/Metastatic GIST Patients Responding to Tyrosine Kinase Inhibitor Treatment: an Observational Study

Who this might be right for
Gastrointenstinal Stromal Tumor (GIST)
The Netherlands Cancer Institute 330
Not applicableStudy completedNCT01764789
What this trial is testing

Stress Reduction in Improving Quality of Life in Patients With Recurrent Gynecologic or Breast Cancer

Who this might be right for
Anxiety DisorderDepressionFatigue+17 more
Ohio State University Comprehensive Cancer Center 39
Early research (Phase 1)Ended earlyNCT04000529
What this trial is testing

Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies

Who this might be right for
Non-small Cell Lung CarcinomaHead and Neck Squamous Cell CarcinomaEsophageal SCC+2 more
Novartis Pharmaceuticals 122
Load More Results